Standing, left to right: Dr. Victor Navarro, Dr. Ramon Bataller, Dr. Marc G. Ghany, Dr.David Kaplan
Seated: Dr. Eyob L. Feyssa, Dr. Guadalupe Garcia-Tsao, Dr. Simona Rossi and Dr. Shuchi K. Rodgers.
The latest developments in the management of liver disease were presented at a Continuing Medical Education conference sponsored by Einstein Healthcare Network on Saturday, December 3. A record number of participants reviewed research and treatment advances, originally reported in November at The Liver Meeting®, an annual conference presented by the American Association for the Study of Liver Diseases (AASLD).
The Einstein conference attracted more than 175 practitioners from the tri-state area—ranging from gastroenterologists, hepatologists and surgeons to non-physician clinicians and nurses—involved in the care of patients with liver disease. Participants were greeted by Barry R. Freedman, Einstein President and CEO; Victor J. Navarro, MD, Co-Chair, Department of Transplantation; and Simona Rossi, MD, Associate Chair, Division of Hepatology. The symposium provided a course overview, nine faculty presentations, and interactive question-and-answer sessions.
Experts in liver disease from around the world gather at AASLD, The Liver Meeting®, every year to review medical breakthroughs, research, and improved treatment modalities. This year’s meeting took place in Boston. The regional course offered by Einstein disseminates that information to the region’s practitioners, which allows them to remain current on the clinical advances of liver disease and provide optimal treatment to their patients.
(At right: Dr. Hitesh Kaul, Associate Program Director for Kidney Transplantation)
Among the topics discussed at Einstein’s event were new drugs to treat hepatitis C; new imaging techniques that increase diagnostic accuracy of hepatic masses; advances in managing post-transplant complications and pre-transplant disease; defining the culture of patient-centered care and new approaches to managing patients with autoimmune, alcohol-related, and fatty liver disease.
Experts who presided over sessions on these topics included Ramon Bataller, MD, PhD, Associate Professor of Medicine at the University of North Carolina School of Medicine; Guadalupe Garcia-Tsao, MD, Professor of Medicine, Yale University School of Medicine and Chief, Digestive Diseases at the VA Connecticut Healthcare System; Marc G. Ghany, MD, investigator with the National Institute of Diabetes, Digestive and Liver Disease at the National Institutes of Health; and David Kaplan, MD, Assistant Professor of Medicine at the University of Pennsylvania and Director of Hepatology at the Philadelphia VA Medical Center.
Three members of Einstein’s faculty joined Drs. Navarro and Rossi in presenting at the conference, including: Eyob L. Feyssa, MD, MPH, Director of the Viral Hepatitis Program, Hitesh Kaul, MD, Associate Program Director for Kidney Transplantation; and Shuchi K. Rodgers, MD, Director of Ultrasound and Body MRI.
“This is our 4th year of bringing state-of- the-art knowledge in the field of hepatology to the community,” Dr. Navarro said.